Biogazelle | GenomeWeb

Biogazelle

Isis will provide Biogazelle with access to its antisense platform for the large-scale validation of therapeutic lncRNA targets from Biogazelle's target identification pipeline.

The accreditation is for the Belgian firm's mRNA, miRNA, and long non-coding RNA expression services.

NEW YORK (GenomeWeb) — Biogazelle said today that it has received a €2 million ($2.5 million) investment from Qbic Arkiv Fund, Foundation Majoie, and SOFI (Spin-Off Financing Instrument).

Core Life Sciences has signed a deal with Biogazelle that lets that company distribute qbase+, Core's software for analyzing qPCR data, in California.

Core Life Sciences said today that it has partnered with Belgium's Biogazelle to distribute its qbase+ qPCR software in California.

NEW YORK (GenomeWeb News) – Core Life Sciences announced this week that it and Biogazelle have reached an agreement to distribute Biogazelle's qbase+ software in California.

Belgium's Flanders Institute for Biotechnology, VIB, has licensed Biogazelle’s qbase+ software to support its real time PCR-based research projects.

BITS, the bioinformatics training and service facility of Belgium's Vlaams Instituut voor Biotechnologie, or VIB, will use Biogazelle's qbase+ software for PCR analysis, Biogazelle said this week.

Bio-Rad this week introduced qPCR assays and panels that have been wet-lab validated to meet the minimum information for publication of quantitative real-time PCR experiments, or MIQE, guidelines.

University of Rochester Medical Center said this week that Hulin Wu, a professor of biostatistics and computational biology, will serve as the founding director of its newly established Center for Integrative Bioinformatics and Experimental Mathematics.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.